Opinion

Video

TAR-200 Clinical Development Program in NMIBC

Experts briefly mention other ongoing phase 3 studies investigating TAR-200 for the treatment of non–muscle-invasive bladder cancer (NMIBC).

Related Videos
1 expert in this video
1 expert in this video
2 experts are featured in this series.
1 expert is featured in this series.
2 experts are featured in this series.
1 expert is featured in this series.
4 experts in this video
Related Content
© 2025 MJH Life Sciences

All rights reserved.